Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 4091
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
61389
I am absolutely certain that Mr. Ehrlich and Dr.
(3)
bandg
12/12/2019 1:57:28 PM
61388
BOM deal can be tied into getting an oral
(3)
djs7
12/12/2019 1:51:48 PM
61387
It would nice to see a BOM deal followed by an
(2)
djs7
12/12/2019 1:31:53 PM
61378
Management continues to move the science forward.
(7)
AlanC
12/11/2019 7:46:07 PM
61377
FINRA short sales of IPIX
(4)
AlanC
12/11/2019 5:35:18 PM
61374
Good to see. I hope LE has a surprise to drop on
(2)
bandg
12/11/2019 3:58:00 PM
61373
The following was in IBD News Weekly Digest in
(8)
Mo
12/11/2019 3:43:53 PM
61372
Alan, well stayed. I believe Sullivans options
grotty
12/11/2019 2:14:00 PM
61369
Those short presently control the price but they
(7)
AlanC
12/11/2019 9:08:34 AM
61368
You mean Glasgow?
(1)
Kelt
12/10/2019 8:12:43 PM
61367
FINRA short sales of IPIX
(2)
AlanC
12/10/2019 5:41:52 PM
61366
Our first B-UPC trial was a PoC phase2 so agree
(4)
williamsc
12/10/2019 4:54:54 PM
61365
WillimSC IPIX ran a 2a so AS could run a 2b/3. I
(1)
bettingbig
12/10/2019 4:29:47 PM
61364
I think it's a fair assumption that our oral
(1)
williamsc
12/10/2019 4:22:55 PM
61363
Interesting question. I believe it will be a
(1)
williamsc
12/10/2019 4:14:55 PM
61361
What Phase Clinical trial does AS have to start
(3)
bettingbig
12/10/2019 3:44:50 PM
61360
Email from IPIX about PR just
(2)
Drano
12/10/2019 3:27:50 PM
61358
same here.
(2)
scgmck1
12/10/2019 1:11:11 PM
61356
All 5 trials in Glaskow. It's were BDD is HQD and
(2)
bettingbig
12/10/2019 12:36:26 PM
61355
Remember that they have a subsidiary in Ireland,
(6)
Drano
12/10/2019 12:10:15 PM
61354
I think it's pretty obvious that the clinical
bettingbig
12/10/2019 11:38:32 AM
61353
How much deeper will the IPIX longs make the
(4)
AlanC
12/10/2019 11:20:51 AM
61352
I got it on my TD Trading platform
(1)
Kelt
12/10/2019 11:20:26 AM
61351
Thanks all, that tells us that something went
(3)
Drano
12/10/2019 11:13:33 AM
61350
I went to the IPIX website Normally I receive an
(2)
Jimvette
12/10/2019 10:55:31 AM
61349
i did not receive the email...got it off my
(1)
Fit007
12/10/2019 10:18:40 AM
61348
rec'd via Fidelity's alert .. currently nothing
(3)
4kids
12/10/2019 10:17:29 AM
61347
Thanks, so I guess it's a bottleneck in the
(1)
Drano
12/10/2019 10:15:02 AM
61346
Not received by me and have had no problem
AlanC
12/10/2019 10:11:50 AM
61345
the "health authorities" thing seems to indicate
(4)
Drano
12/10/2019 10:10:21 AM
61344
Did people get this PR via email? I didn't --
(1)
Drano
12/10/2019 10:08:24 AM
61343
Update on Ulcerative Colitis Program Separately,
(1)
Fit007
12/10/2019 9:46:34 AM
61341
Shorts putting on a full court press at the swamp
(3)
AlanC
12/10/2019 9:34:44 AM
61337
FINRA short sales of ,IPIX
(5)
AlanC
12/09/2019 8:13:35 PM
61336
Longs continuing to take advantage of the shorts
(4)
AlanC
12/09/2019 4:52:08 PM
61334
Unbelievable numbers. By 2024 cancer drug
(7)
petemantx
12/09/2019 4:14:10 PM
61333
Big Drugmakers Push Deeper Into Cancer Treatment
(7)
AlanC
12/09/2019 2:59:56 PM
61331
$2.5 billion for a phase 1 cancer drug. The
(1)
DoraBrown
12/09/2019 1:54:01 PM
61328
France's Sanofi to buy biotech firm Synthorx for
(3)
NotRichYet2
12/09/2019 8:40:30 AM
61323
https://safetyprogram4antibioticstewardship.org/p
(2)
annakneemuss
12/08/2019 8:25:35 PM
61322
Seeing that M'goo & Bzo (and others) are all the
(3)
Kelt
12/08/2019 8:19:31 PM
61315
It does boggle the mind. Give a small payment of
(5)
DoraBrown
12/08/2019 12:04:22 PM
61314
Lichen planus is a very uncomfortable condition
(4)
grotty
12/08/2019 11:07:25 AM
61313
Heard they tast like chicken?
(1)
annakneemuss
12/08/2019 12:00:28 AM
61312
Do you even know what lichen planes
(2)
grotty
12/07/2019 2:17:19 PM
61311
I wonder if B swish and spit will be effective on
(1)
grotty
12/07/2019 12:39:07 PM
61310
Love it Kelt...take down all the fraudulent
(1)
Fit007
12/07/2019 10:45:17 AM
61309
Again,FU Magoo (and your other aliases) (I see
(2)
Kelt
12/06/2019 10:17:46 PM
61306
FU Magoo Kelt
(2)
Kelt
12/06/2019 9:59:46 PM
61305
Such poor little snowflakes.Shame they can't
(2)
Kelt
12/06/2019 9:42:02 PM
Newer
Older
Recent Articles
Understanding Coinbase Global Inc's Stock Surge and Market Impact
Umicore Receives Major Shareholding Notification from BlackRock
Unveiling the Growth of a $100 Investment in SPG Stocks
Navigating the Challenges of Deepfake Technology for Small Biz
Robinhood's Stock Surge: Key Factors Behind the Record Highs
Kering's Monthly Share and Voting Rights Update for 2025
Exploring the Innovative AAS Miner AI Bitcoin Cloud Platform
Assessing Market Sentiment for Cognizant Tech Solutions
Exploring the Polymer Market Boom in the EV Industry Ahead
Kering's Monthly Share and Voting Rights Update for Investors
Understanding Investor Sentiments on Moodys: A Deep Dive
Insights on Sempra's Short Interest and Market Sentiment
Shell's Strategic Share Buy-Back: Key Details Explained
GameStop's CEO Ryan Cohen Speaks Against Short Selling Practices
Independent Bank's Earnings Preview: What to Expect
Simmons First National Corp's Earnings Before the Announcement
Webster Financial's Upcoming Earnings Release Insights
Understanding ManpowerGroup's Financial Landscape and Future
Analyzing OFG Bancorp's Upcoming Earnings and Market Trends
FyterTech Welcomes Matt Wild as New CEO for Future Growth
House Appropriations Bill Could Undermine Tobacco Control Efforts
Crescendo and Amazon Innovate Voice AI for Enhanced CX
Kathryn Henry's Inspirational Memoir Captures Hearts Worldwide
Growth of Energy as a Service Market to Reach $193.7 Billion
Exploring the Future of Bio Based Propylene Glycol Market
Lightchain AI Enhances Community Engagement with Bonus Round Launch
KGNCloud's Innovative Trial Mining Program: A Game Changer
BloFin Revolutionizes Cryptocurrency Trading with Apple Pay
JCDecaux's Latest Financial Insights and Market Performance Update
BlackRock's Recent Stake Adjustment in Umicore's Holdings
Circle Internet Group (CRCL) Soars Amid Stablecoin Bill Progress
How $100 Invested in Moody's 15 Years Ago Has Grown
Understanding Shareholder Rights in Merger Investigations
Unlocking Value: A Deep Dive into JCDecaux's Liquidity Strategy
Understanding the Current Challenges Facing NIO Stock Prices
Real Estate Sector: Analyzing Unprecedented Buy Opportunities
Navigator Group Purchasing Partners with Foodbuy for Enhanced Services
NCAA President Charlie Baker to Discuss College Sports Evolution
NVIDIA's Sales Surge: The Greenlight for Growth Ahead
James Wynn's Risky Return to High-Leverage Bitcoin Trading
ProLogic ITS Partners with Signal 8 to Enhance Public Safety
Unity Software Experiences Stock Surge Following Analyst Upgrade
Kezar Life Sciences Advances in Autoimmune Hepatitis Trials
OSE Immunotherapeutics Reveals Recent Liquidity Contract Update
IPSEN's Recent Buy-Back Activities: Insights and Analysis
Exosens Expands Night Vision Capabilities Through NVLS Deal
Investment Growth: What $1000 in RB Global Could Yield
Zensai's Major Recognition as a Leading AI Innovator
Investigation Launched: Potential Class Action Against WAMCO
Guideline Faces Recommendations on 401(k) Claims from NAD